CCAT2 and gastric cancer: The experimental results suggest that lncRNA CCAT2 upregulates the expression of CD44v6 by binding to ESRP1, thereby mediating the selective splicing of CD44 and promoting the development of gastric cancer, which is associated with shorter patient survival (61).